LIVE

LEGN

Legend Biotech Corporation

LEGN

NASDAQ·Healthcare·Biotechnology·Mkt cap $5.5B

$29.66

-0.77%

View full research view

Our plain-language verdict, the thesis, risk factors, and what is changing about the business.

View research view

52-Week Range

$16.24 - $45.30

P/E

-98.87

Fwd P/E

35.98

Beta

0.35

Div Yield

0.00%

Avg Vol

2.8M

Shares Out

Mkt Cap

$5.5B

Price action

Price chart

Down 16.8% over the trailing year

1W
1M
3M
6M
YTD
1Y
5Y
MAX

Total returns

Price performance

Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.

Why we rate it this way

The thesis at a glance

Bull and bear case · plain-English context across the five lenses we evaluate.

Bull Case

No bull reasons captured for this rating yet.

Bear Case

2 risks

  • Low volatility (beta 0.4).
  • Significant premium - growth priced in

Growth

Turning profitable

Value

Significant premium - growth priced in

Momentum

Hot

+56.2% over 3m

Quality

Strong

Mixed fundamentals

Dividend

None

No dividend

Earnings track record

Recent earnings results

AI-summarized recap of last quarter, plus the surprise on every print.

Next: Aug 10, 2026

LATEST RECAP

Earnings recap unavailable for this period.

EPS surprise · last 4Q

Q1 26

-$0.30

Next: Aug 10, 2026

Revenue trend · last 1Q

Q1 26

$305.1M

Margins · last 1Q

Profit

-17.8%

Wall Street consensus

4 analysts · 75% Buy

Live ratings and price targets aggregated across covering analysts.

Buy

3

75%

Hold

1

25%

Sell

0%

Median Price Target

$56.50

+90.5% vs $29.66

Low $48.00
Median $56.50
High $65.00

Latest: HC Wainwright · $65.00 · Jun 3, 2026

4 analysts covering

vs Industry

How LEGN stacks vs Biotechnology

Stock metrics vs industry averages. Green = better than industry.

Industry comparison data unavailable for this stock.

Related

Peers & themes

Peers

No peer data available.

Themes

No themes assigned.